- Home
- OCTO vs SCNI Comparison
OCTO vs SCNI Comparison
Compare OCTO & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCTO
- SCNI
- Stock Information
- Founded
- OCTO 1966
- SCNI 2003
- Country
- OCTO United States
- SCNI Israel
- Employees
- OCTO N/A
- SCNI N/A
- Industry
- OCTO
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OCTO
- SCNI Health Care
- Exchange
- OCTO Nasdaq
- SCNI Nasdaq
- Market Cap
- OCTO 3.4M
- SCNI 3.5M
- IPO Year
- OCTO N/A
- SCNI N/A
- Fundamental
- Price
- OCTO $2.48
- SCNI $3.65
- Analyst Decision
- OCTO
- SCNI
- Analyst Count
- OCTO 0
- SCNI 0
- Target Price
- OCTO N/A
- SCNI N/A
- AVG Volume (30 Days)
- OCTO 5.5M
- SCNI 31.9K
- Earning Date
- OCTO 11-12-2024
- SCNI 10-29-2024
- Dividend Yield
- OCTO N/A
- SCNI N/A
- EPS Growth
- OCTO N/A
- SCNI N/A
- EPS
- OCTO N/A
- SCNI N/A
- Revenue
- OCTO $55,497,449.00
- SCNI $284,000.00
- Revenue This Year
- OCTO N/A
- SCNI N/A
- Revenue Next Year
- OCTO N/A
- SCNI N/A
- P/E Ratio
- OCTO N/A
- SCNI N/A
- Revenue Growth
- OCTO N/A
- SCNI N/A
- 52 Week Low
- OCTO $1.26
- SCNI $2.23
- 52 Week High
- OCTO $4.86
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- OCTO 56.51
- SCNI 48.94
- Support Level
- OCTO $1.78
- SCNI $3.52
- Resistance Level
- OCTO $2.51
- SCNI $3.94
- Average True Range (ATR)
- OCTO 0.21
- SCNI 0.27
- MACD
- OCTO -0.01
- SCNI 0.00
- Stochastic Oscillator
- OCTO 79.55
- SCNI 52.31
About OCTO Eightco Holdings Inc.
Eightco Holdings Inc operates in three main businesses: Forever 8 Inventory Cash Flow Solution, Web3 Business, and Packaging Business. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Web3 Business but has no intention of continuing this business at this time. The Packaging Business manufactures and sells custom packaging for a wide variety of products and helps customers generate brand awareness and promote brand image through packaging. The Company's two reportable segments were the Inventory Management Solutions segment and the Corrugated segment. Key revenue is generated from Inventory Management Solutions segment.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.